Podocyte injury promotes progressive nephropathy in zucker diabetic fatty rats

Laboratory Investigation

Volumn 82, Issue 1, 2002, Pages 25-35

  Hoshi, Sachi ^a   Shu, Yujing ^a   Yoshida, Fusayo ^b   Inagaki, Tomoko ^c   Sonoda, Jiro ^b   Watanabe, Teruo ^a   Nomoto, Ken Ichi ^b   Nagata, Michio ^a  

^a UNIVERSITY OF TSUKUBA   (Japan)

^b EISAI CO LTD   (Japan)

^c SHOWA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN TYPE 4; CYCLIN DEPENDENT KINASE INHIBITOR; DESMIN; FIBRONECTIN; GLUCOSE; INSULIN; MESSENGER RNA; PROTEIN P21; PROTEIN P27; VASCULOTROPIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL DEGENERATION; CONTROLLED STUDY; DIABETIC NEPHROPATHY; DISEASE MODEL; ELECTRON MICROSCOPY; GENETIC RESISTANCE; GLUCOSE METABOLISM; HISTOPATHOLOGY; IMPAIRED GLUCOSE TOLERANCE; INSULIN RESISTANCE; KIDNEY DISEASE; MALE; MEMBRANOUS GLOMERULONEPHRITIS; MESANGIUM CELL; MORPHOMETRICS; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PATHOPHYSIOLOGY; PODOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEINURIA; STRESS;

AGING; ANIMALS; BLOOD GLUCOSE; CELL LINE; COLLAGEN TYPE IV; DIABETES MELLITUS, TYPE 2; DIABETIC NEPHROPATHIES; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; ENDOTHELIAL GROWTH FACTORS; EPITHELIAL CELLS; FIBRONECTINS; GLOMERULAR FILTRATION RATE; INSULIN RESISTANCE; KIDNEY; LYMPHOKINES; MICE; RATS; RATS, ZUCKER; TRANSCRIPTION, GENETIC; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0036144851     PISSN: 00236837     EISSN: None     Source Type: Journal    
DOI: 10.1038/labinvest.3780392     Document Type: Article

References (33)

1. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenolchloroform extraction
2. Prevention of diabetic nephropathy in db/db mice with glycated albumin antagonists
3. Early events leading to renal injury in obese zucker (fatty) rats with type II diabetes
4. Simplification of the anthrone method for the determination of inulin in clearance studies
5. Rodent genetic models for obesity and non-insulin-dependent diabetes mellitus
6. Lipogenesis in situ in the genetically obese zucker fatty rat (fa/fa): Role of hyperphagia and hyperinsulinaemia
7. Production of spontaneous diabetic rats by repetition of selective breeding
8. Laboratory animal exhibiting obesity and diabetes syndromes
9. Regulation of vascular smooth muscle cell proliferation by nuclear factor-kappaB and its inhibitor, I-kappaB
10. Diabetes, new mutation in the mouse
11. A new genetically obese-hypergkycemic rat (Wistar fatty)
12. Spontaneous long-term hyperglycemic rat with diabetic complications: Otuka Long-Evans Tokushima Fatty (OLETF) strain
13. The role of podocytes in the development of glomerular sclerosis
14. Long-term treatment of rats with FGF-2 results in focal segmental glomerulosclerosis
15. The cyclin kinase inhibitor p21WAF1. CIP1 is increased in experimental diabetic nephropathy: Potential role in glomerular hypertrophy
16. Rearrangements of the cytoskeleton and cell contacts induce process formation during differentiation of conditionally immortalized mouse podocytes cell lines
17. Glomerular damage after uninephrectomy in young rats. II. Mechanical stress on podocytes as a pathway to sclerosis
18. Cell cycle regulation and differentiation of the human podocytes lineage
19. Studies on a diabetic strain of the mouse
20. Progression of nephropathy in spontaneous diabetic rats is prevented by OPB-9195, a novel inhibitor of advanced glycation
21. Urinary excretion of podocytes in patients with diabetic nephropathy
22. Clinical and pathological course of renal disease in noninsulin-dependent diabetes mellitus: The Pima Indian experience
23. Glomerular expression of cell-cycle-regulatory proteins in human crescentic glomerulonephritis
24. The cyclin-dependent kinase inhibitor p27Kip1 safeguards against inflammatory injury
25. Podocytes loss and progressive glomerular injury in type II diabetes
26. Progression of diabetic nephropathy: Insights from cell culture studies and animal models
27. Diabetic nephropathy in type II diabetes
28. Cyclin kinase inhibitors are increased during experimental membranous nephropathy: Potential role in limiting glomerular epithelial cell proliferation in vivo
29. Suppression of transforming growth factor beta and vascular endothelial growth factor in diabetic nephropathy in rats by a novel advanced glycation end product inhibitor, OPB-91485
30. Evolution of metabolic and renal changes in the ZDF/Drt-fa rat model of type II diabetes
31. Glomerular expression of p27Kip1 in diabetic db/db mouse: Role of hyperglycemia
32. Characteristics of diabetes, blood pressure, and cardiac and renal complications in otsuka long-evans tokushima fatty rats
33. Variable expression of desmin in rat glomerular epithelial cells